| |
| |
|
| Insider
Information: |
Behbahani Ali |
| Relationship: |
Director |
| City: |
Timonium |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
19 |
|
| Direct
Shares |
66,478 |
|
|
Indirect Shares
|
101,863,965 |
|
|
| Direct
Value |
$383,912 |
|
|
|
Indirect Value
|
$363,197,122 |
|
|
| Total
Shares |
101,930,443 |
|
|
| Total
Value |
$363,581,034 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 8.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nevro Corp |
NVRO |
Director |
2018-05-21 |
5,390 |
2015-12-02 |
0 |
Premium* |
|
|
Crispr Therapeutics Ag |
CRSP |
Director |
2020-08-13 |
256 |
2020-08-13 |
14 |
Premium* |
|
|
Adaptimmune Therapeutics PLC |
ADAP |
Director |
2018-09-07 |
0 |
2020-01-24 |
19,500,000 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
Director, 10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
2019-05-07 |
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2023-06-13 |
135 |
Premium* |
|
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2024-03-15 |
51,690 |
2024-03-15 |
4,448,757 |
Premium* |
|
|
Oyster Point Pharma, Inc. |
OYST |
Director |
2023-01-03 |
0 |
2020-06-08 |
0 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
|
Monte Rosa Therapeutics, Inc. |
GLUE |
Director, 10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
Bright Health Group Inc. |
BHG |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
|
Minerva Surgical Inc |
UTRS |
Director |
2021-10-26 |
8,487 |
2021-10-26 |
0 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
Director |
2023-06-01 |
339 |
2023-06-01 |
85 |
Premium* |
|
|
Korro Bio |
KRRO |
|
2023-11-03 |
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
Cvrx, Inc. |
CVRX |
Director |
2023-12-14 |
316 |
2023-12-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRRO |
Korro Bio |
|
– • • |
2024-04-22 |
4 |
A |
$56.00 |
$999,992 |
I/I |
17,857 |
1,090,793 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
|
– • – |
2024-03-15 |
4 |
A |
$4.54 |
$14,374 |
D/D |
3,166 |
51,690 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • – |
2023-12-15 |
4 |
A |
$2.73 |
$12,162 |
D/D |
4,455 |
48,524 |
0 |
- |
|
| CVRX |
Cvrx, Inc. |
Director |
– • – |
2023-12-14 |
4 |
OE |
$0.24 |
$75 |
D/D |
316 |
316 |
0 |
- |
|
| KRRO |
Korro Bio |
Director |
– • • |
2023-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,072,936 |
1,072,936 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • – |
2023-09-15 |
4 |
A |
$3.60 |
$11,876 |
D/D |
3,299 |
44,069 |
0 |
- |
|
| SVRA |
Savara Inc |
10% Owner |
– – • |
2023-07-17 |
4 |
B |
$3.00 |
$999,999 |
I/I |
333,333 |
24,471,264 |
1.5 |
% |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • – |
2023-07-05 |
4 |
B |
$5.00 |
$5,000,000 |
I/I |
1,000,000 |
4,448,757 |
2.1 |
% |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • – |
2023-06-16 |
4 |
A |
$2.10 |
$11,876 |
D/D |
5,655 |
40,770 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
– – • |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,135 |
135 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
– – • |
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
28 |
85 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
113 |
339 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • – |
2023-03-16 |
4 |
A |
$1.67 |
$11,875 |
D/D |
7,111 |
35,115 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2023-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,639) |
0 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
226 |
226 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
57 |
57 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • – |
2022-12-16 |
4 |
A |
$1.50 |
$11,876 |
D/D |
7,917 |
28,004 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
10% Owner |
– – • |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,294,207) |
0 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • – |
2022-09-16 |
4 |
A |
$2.62 |
$11,874 |
D/D |
4,532 |
20,087 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
Director |
– • – |
2022-06-17 |
4 |
A |
$2.03 |
$11,876 |
D/D |
5,850 |
15,555 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
13,639 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
Director |
– • • |
2022-05-25 |
4 |
S |
$0.08 |
$362,720 |
I/I |
(4,445,093) |
0 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
Director |
– • • |
2022-05-24 |
4 |
S |
$0.07 |
$387,943 |
I/I |
(5,931,843) |
4,445,093 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2022-04-11 |
4 |
B |
$1.90 |
$6,802,999 |
I/I |
3,580,526 |
948,948 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
